What Is Neurofibromatosis: Causes, Symptoms, Diagnosis, and Treatment Options

Neurofibromatosis (NF) is a genetic condition that affects the nerves and skin and can cause benign tumors, skin changes, and, in some cases, complications in the brain and spinal cord. If you or someone you care about notices unusual skin spots, lumps along nerves, or new neurological symptoms, NF is a possible cause worth evaluating because early diagnosis guides monitoring and treatment.

This article What Is Neurofibromatosis will explain what NF means, the different types you might encounter, how clinicians diagnose it, and the treatment and daily-management options that help people stay as healthy and independent as possible. You’ll get clear, practical information so you can recognize signs, ask the right questions at appointments, and understand the path forward.

Understanding Neurofibromatosis

Neurofibromatosis affects nerves, skin, and sometimes the brain and spine. It includes distinct types with different risks, genetic causes, and typical signs you can observe or test for.

Definition and Types of Neurofibromatosis

Neurofibromatosis (NF) refers to inherited genetic disorders that increase the risk of nerve-related tumors. The main types are NF1, NF2 (often called NF2-related schwannomatosis), and schwannomatosis.
NF1 is the most common and typically causes multiple cutaneous neurofibromas, café-au-lait spots, and freckles in skin folds. NF2 mainly causes bilateral vestibular schwannomas (hearing nerve tumors) and other cranial or spinal schwannomas. Schwannomatosis leads to multiple painful schwannomas without the vestibular tumors typical of NF2.

Each type differs in age of onset, tumor types, and complications. Diagnosis relies on clinical criteria, imaging (MRI), and increasingly on genetic testing to identify causative gene variants.

Causes and Genetic Basis

You develop NF because of pathogenic variants in specific genes that regulate cell growth in nerve tissue. NF1 results from variants in the NF1 gene on chromosome 17, which encodes neurofibromin, a tumor suppressor that regulates cell signaling. Loss of neurofibromin increases cell proliferation along nerves.
NF2 stems from variants in the NF2 gene on chromosome 22, which encodes merlin (schwannomin), another tumor suppressor. Schwannomatosis involves mutations in SMARCB1 or LZTR1 combined with somatic changes in NF2 in tumor tissue.

Inheritance is autosomal dominant: a single altered copy can cause disease. Up to about half of NF1 cases arise from new (de novo) mutations, so you may have the condition without a family history. Genetic testing and counseling clarify your risk of passing NF to children.

Common Signs and Symptoms

Look for skin and nerve findings that vary by type and age. For NF1, common early signs include multiple café-au-lait macules (light brown patches), axillary or inguinal freckling, and soft cutaneous neurofibromas that appear over time. Plexiform neurofibromas can be present at birth and may cause disfigurement or functional problems.
In NF2, hearing loss, tinnitus, or balance problems from bilateral vestibular schwannomas are common initial complaints. You may also develop intracranial meningiomas or spinal schwannomas causing focal neurological deficits.

Cognitive issues, learning disabilities, and attention problems are frequent in NF1. Pain, numbness, or weakness can occur with any NF type when tumors compress nerves. Regular surveillance with clinical exams and MRI helps detect complications early.

Diagnosis, Treatment, and Living with Neurofibromatosis

You will need specific tests to confirm a diagnosis, a tailored treatment plan that addresses symptoms and tumor risks, and ongoing monitoring to manage complications and preserve function.

Diagnostic Procedures

Diagnosis typically begins with a focused clinical exam looking for café-au-lait spots, freckling in skin folds, Lisch nodules on the iris, and palpable neurofibromas. A medical history that includes family history of NF1, NF2, or schwannomatosis guides testing decisions.

Genetic testing (blood or saliva) can detect pathogenic variants in NF1, NF2, or SMARCB1/LZTR1 for schwannomatosis. Imaging studies support diagnosis and surveillance:

• MRI of brain and spine for assessing intracranial or spinal tumors (vestibular schwannomas in NF2).
• Ultrasound or targeted MRI for plexiform neurofibromas. Biopsy is rarely required for typical neurofibromas but may be used if malignancy is suspected. You should receive counseling about inheritance patterns and reproductive options before and after genetic testing.

Treatment Options and Management

Treatment aims to control symptoms, remove or reduce tumor burden when necessary, and maintain quality of life. Options include:

• Surgery: removal of symptomatic or disfiguring tumors, and decompression for spinal or nerve compression.
• Medication: FDA-approved targeted therapies (e.g., MEK inhibitors for symptomatic plexiform neurofibromas) and standard pain medications or antiemetics as needed.
• Radiation and chemotherapy: used selectively for malignant peripheral nerve sheath tumors or other cancers related to NF. Coordinate care with a multidisciplinary team—neurology, neurosurgery, dermatology, oncology, pain management, and genetics. Regular surveillance schedules (clinical exams, MRI intervals based on NF type and findings) help detect changes early. Rehabilitation, physical therapy, and psychosocial support address function and mental health.

Potential Complications and Prognosis

Complications vary by type and individual disease burden. Common issues for NF1 include plexiform neurofibromas that may cause pain, disfigurement, or nerve dysfunction, and increased risk of certain tumors including malignant peripheral nerve sheath tumors. NF2 commonly causes bilateral vestibular schwannomas leading to hearing loss, balance problems, and facial nerve issues.

Prognosis depends on tumor location, growth behavior, and complications. Early detection and treatment improve outcomes for tumors and functional impairments. Lifelong follow-up is essential; you should expect periodic imaging, hearing tests (for NF2), ophthalmologic exams (for children with NF1), and prompt evaluation of new or rapidly changing lesions. Genetic counseling helps you understand recurrence risk and family planning implications.